"Compared to the previous edition, the percentages estimates of dense tissue were replaced by a description of subjectively estimated breast density associated with changes in the sensitivity of mammography. This emphasises the masking effect of dense tissue on mammographic detection of non-calcified lesions. The exact percentage of breast density is more relevant as a factor in stratification of breast cancer risk1."
"Compared to the previous edition, the percentages estimates of dense tissue were replaced by a description of subjectively estimated breast density associated with changes in the sensitivity of mammography. This emphasises the masking effect of dense tissue on mammographic detection of non-calcified lesions. The exact percentage of breast density is more relevant as a factor in stratification of breast cancer risk1."
"Compared to the previous edition, the percentages estimates of dense tissue were replaced by a description of subjectively estimated breast density associated with changes in the sensitivity of mammography. This emphasises the masking effect of dense tissue on mammographic detection of non-calcified lesions. The exact percentage of breast density is more relevant as a factor in stratification of breast cancer risk1."
"vitamin D and calcium intake in pre-menopausal women"
"There are four descriptors for breast density on mammography in the 5th edition of BI-RADS 1,2:"
"There are analogous BI-RADS categories for the amount of fibroglandular tissue on breast MRI:"
Expected headings
"Significance"
"Factors that can increase breast density"
"Factors that can decrease breast density"
"There are four descriptors for breast density on mammography in the 5th edition of BI-RADS 1,2:"
"There are analogous BI-RADS categories for the amount of fibroglandular tissue on breast MRI:"
"In dense breasts, screening ultrasound is potentially beneficial. Contrast-enhanced MRI is also advocated as an adjunct to screening mammography in extremely dense breasts; however, no large data is available in this regard. The DENSE Trial is undergoing to evaluate MRI as an additional screening tool in women aged 50-75 years with extremely dense breasts 5."